Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer-Reference-Cited by-同舟云学术

Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer

Published:2008-06-18 Issue:6 Volume:3 Page:e2409
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kuhn Irene,Harden Paul,Bauzon Maxine,Chartier Cecile,Nye Julie,Thorne Steve,Reid Tony,Ni Shaoheng,Lieber Andre,Fisher Kerry,Seymour Len,Rubanyi Gabor M.,Harkins Richard N.,Hermiston Terry W.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference61 articles.

1. Proteins, drug targets and the mechanisms they control: the simple truth about complex networks.;RP Araujo;Nat Rev Drug Discov,2007

2. “Who should receive epidermal growth factor receptor inhibitors for non-small cell lung cancer and when?”;CL Hann;Curr Treat Options Oncol,2007

3. Molecular-targeted therapies: Lessons from years of clinical development.;DD Rosa;Cancer Treat Rev,2007

4. Recent progress in the battle between oncolytic viruses and tumours.;KA Parato;Nat Rev Cancer,2005

5. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.;FR Khuri;Nat Med,2000

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonclinical characterization of ICVB-1042 as a selective oncolytic adenovirus for solid tumor treatment;Communications Biology;2024-09-13

2. Advances in the therapeutic study of oncolytic virus in colorectal cancer;Oncology and Translational Medicine;2024-07-02

3. E4orf1: The triple agent of adenovirus – Unraveling its roles in oncogenesis, infectious obesity and immune responses in virus replication and vector therapy;Tumour Virus Research;2024-06

4. Combining CRISPR-Cas-mediated terminal resolution with a novel genetic workflow to achieve high-diversity adenoviral libraries;Molecular Therapy - Methods & Clinical Development;2024-06

5. Fast Track Adaptation of Oncolytic Coxsackie B3 Virus to Resistant Colorectal Cancer Cells - a Method to Personalize Virotherapy;Biological Procedures Online;2024-04-25